Correlation between arterial wall stiffness, N-terminal prohormone of brain natriuretic peptide, functional and structural myocardial abnormalities in patients with type 2 diabetes mellitus and cardiac autonomic neuropathy

Aim.
To assess arterial wall stiffness, plasma levels of of N-terminal prohormone of brain natriuretic peptide (NT-proBNP), as well as functional state and structure of the myocardium in patients with type 2 diabetes mellitus (T2DM) and cardiac autonomic neuropathy (CAN).
Materials and Methods.
The study involved a total of 65 patients with T2DM. 12 had no evidence of cardiovascular disease (CVD) or CAN, 14 were diagnosed with subclinical stage of CAN, 18 ? with functional stage, and 21 ? with organic stage. We measured aortic pulse wave velocity (PWV), aortic augmentation index (AIx), brachial artery AIx, ambulatory arterial stiffness index (AASI) and plasma levels of NT-proBNP. Clinical examination included ECG, Holter monitoring, ambulatory BP measurement and echocardiography.
Results.
 Patients with isolated T2DM showed a trend for increased vascular wall stiffness. PWV was increased in patients with subclinical stage of CAN. Aortic and brachial AIx, PWV and AASI were elevated in patients with functional stage of CAN, PWV being significantly higher vs. subclinical CAN subgroup. Organic stage was characterized by pathologically increased values of all primary parameters; PWV and AASI were significantly higher compared with other groups. Development and progression of CAN was accompanied by an increase in NT-proBNP plasma levels. Concentration of NT-proBNP was in direct correlation with left ventricular mass (LVM) and PWV. PWV and LVM values also directly correlated between themselves.
Conclusion.
Development and progression of CAN in patients with T2DM is accompanied by an increase in vascular wall stiffness. The elevation of plasma NT-proBNP in patients with T2DM correlates with the development of CAN and is significantly and independently associated with an increase in LVM and PWV. Our data suggests the pathophysiological interconnection between metabolic, functional and structural myocardial abnormalities in patients with T2DM and CAN.

type 2 diabetes mellitus, cardiac autonomic neuropathy, arterial wall stiffness, brain natriuretic peptide, myocardium

1. Дедов ИИ, Шестакова МВ. Сахарный диабет: диагностика, лечение, профилактика. М: МИА;2011.

2. [ Dedov II, Shestakova MV. Diabetes mellitus: diagnostics, treatment, prophylaxis. Moscow: MIA;2011.]

3. Tesfaye S, Boulton AJM, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments. Diabetes Care. 2010;33(10):2285–2293.

4. DOI: 10.2337/dc10-1303.

5. Vinik AI, Ziegler D. Diabetic Cardiovascular Autonomic Neuropathy. Circulation 2007;115(3):387–397.

6. DOI: 10.1161/CIRCULATIONAHA.106.634949.

7. Бойцов СА, Карпов ЮА, Кухарчук ВВ, Рогоза АН, Балахонова ВТ, Уразалина СЖ, и соавт. Проблемы выявления лиц с высоким сердечно-сосудистым риском и возможные пути их решения (ч. 1). Атеросклероз и дислипидемии. 2010;(1):8–14.

8. [Boytsov SA, Karpov YuA, Kukharchuk VV, Rogoza AN, Balakhonova TV, Urozalina SJ, et al. Identification of Patients at High Cardiovascular Risk: Problems and Possible Solutions. (Part I). Atherosclerosis and dyslipidemias. 2010;(1):8–14.]

9. Лукьянов ММ, Бойцов СА. Жесткость артериальной стенки как фактор сердечно-сосудистого риска и прогноза в клинической практике. Сердце 2010;9(3):156–158.

10. [Lukyanov MM, Boitsov SA. Arterial wall rigidity as cardiovascular risk and prognostic factor in clinical practice. Serdtse: Zhurnal Dlya Praktikuyushcikh Vrachey. 2010;9(3):156–158.]

11. Babes E. Value of N-Terminal Pro-B-Type Natriuretic Peptide in Detecting Silent Ischemia and its Prognostic Role in Asymptomatic Patients with Type 2 Diabetes Mellitus. Acta Endocrinologica (Buc) 2011;7(2):209–218.

12. DOI: 10.4183/aeb.2011.209.

13. Сергиенко ВО, Сергиенко ОО, Ефімов АС. Рання діагностика функціонально-структурних порушень серцево-судинної системи у хворих на цукровий діабет 2-го типу (огляд літератури та власних досліджень). Журн АМН України. 2010;16(4):630–650.

14. [Sergyenko VO, Sergyenko OO, Efimov AS. Rannja diagnostyka funkcional'no-strukturnyh porushen' sercevo-sudynnoi' systemy u hvoryh na cukrovyj diabet 2-go typu (ogljad literatury ta vlasnyh doslidzhen'). Zhurnаl AMN Ukrai'ny. 2010;16(4):630–650].

15. Рогоза АН, Ощепкова ЕВ, Цагареишвили ЕВ, Гориева ШБ. Современные неинвазивные методы измерения артериального давления для диагностики артериальной гипертонии и оценки эффективности антигипертензивной терапии. М: Медика; 2007.

16. [Rogoza AN, Oshchepkova EV, Tsagareishvili EV, Gorieva ShB. Sovremennye neinvazivnye metody izmereniya arterial'nogo davleniya dlya diagnostiki arterial'noy gipertonii i otsenki effektivnosti antigipertenzivnoy terapii. M: Medika; 2007.]

17. Иваненко ВВ, Ротарь ОП, Конради АО. Взаимосвязь показателей жесткости сосудистой стенки с различными сердечно-сосудистыми факторами риска. Артериальная гипертензия. 2009;15(3):290-295.

18. [Ivanenko VV, Rotar OP, Konradi AO. Association of arterial wall stiffness with cardiovascular risk factors. Arterial Hypertension. 2009;15(3):290–295.]

19. Gómez-Marcos MA, Recio-Rodríguez JI, Patino-Alonso MC, Agudo-Conde C, Gómez-Sánchez L, Rodríguez-Sánchez E, et al. Relationship between intima-media thickness of the common carotid artery and arterial stiffness in subjects with and without type 2 diabetes: a case-series report. Cardiovascular Diabetology. 2011;10(1):3–8.

20. DOI: 10.1186/1475-2840-10-3

21. Ozasa N, Furukawa Y, Morimoto T, Tadamura E, Kita T, Kimura T. Relation among Left Ventricular Mass, Insulin Resistance, and Hemodynamic Parameters in Type 2 Diabetes. Hypertension Research. 2008;31(3):425–432.

22. DOI: 10.1291/hypres.31.425

23. Wang M, Chang N, Liu J, Tsai P. Aortic Augmentation Index is not a Useful Index of Cardiovascular Risk in Type 2 Diabetes. Journal of Experimental & Clinical Medicine. 2011;3(2):70–73.

24. DOI: 10.1016/j.jecm.2011.02.002

25. Stergiou GS, Kollias A, Rarra VC, Roussias LG. Ambulatory Arterial Stiffness Index: Reproducibility of Different Definitions. American Journal of Hypertension. 2010;23(2):129–134.

26. DOI: 10.1038/ajh.2009.217

27. Triantafyllidi H, Tzortzis S, Lekakis J, Ikonomidis I, Arvaniti C, Trivilou P, et al. Association of target organ damage with three arterial stiffness indexes according to blood pressure dipping status in untreated hypertensive patients. American Journal of Hypertension. 2010;23(12):1265–1272.

28. DOI: 10.1038/ajh.2010.156

29. Kikuya M, Staessen JA, Ohkubo T, Thijs L, Asayama K, Satoh M, et al. How many measurements are needed to provide reliable information in terms of the ambulatory arterial stiffness index the Ohasama study. Hypertension Research. 2011;34(3):314–318.

30. DOI: 10.1038/hr.2010.240

31. Hamano K, Abe M, Komi R, Kobayashi S. N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) for predicting silent myocardial ischaemia in type 2 diabetes mellitus independent of microalbuminuria. Diabetes/Metabolism Research and Reviews. 2010;26(7):534–539.

32. DOI: 10.1002/dmrr.1113